73475-1221Level 3
VYVGART Hytrulo (efgartigimod alfa and hyaluronidase (human recombinant))
**Product type:** Human Prescription Drug
**Active ingredient:** EFGARTIGIMOD ALFA; HYALURONIDASE (HUMAN RECOMBINANT)
**Strength:** 200; 2000 mg/mL; U/mL
**Dosage form:** Injection, Solution
**Route:** Subcutaneous
**Labeler:** argenx US
**Marketing category:** BLA (BLA761304)
**Pharmacologic class:** Endoglycosidase [EPC], Glycoside Hydrolases [CS], Neonatal Fc Receptor Blocker [EPC], Neonatal Fc Receptor Blockers [MoA]
GET
/api/v1/systems/ndc_fda/nodes/73475-1221Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.